Drug Profile
Research programme: chloride channel modulators - Chlorion Pharma
Alternative Names: CL-301; CLP-290Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Chlorion Pharma
- Class Small molecules
- Mechanism of Action Chloride channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurological disorders; Neuropathic pain; Partial epilepsies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neurological-disorders in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Neuropathic-pain in USA
- 16 Jul 2016 No recent reports of development identified for preclinical development in Partial-epilepsies in USA